An Observational Study Called H2H-OSCAR-US to Learn More About How Well Rivaroxaban Works and How Safe it is Compared to Apixaban Under Real World Conditions in People in the US With Cancer Who Have Problems Due to Formation of Blood Clots in the Veins (Venous Thromboembolism)
Clinical trial NCT05461807 · COMPLETED
Trial details
- NCT number
- NCT05461807
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-07-14
- Primary completion
- 2022-10-05
- Enrollment
- 2437
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.